What happened?

On 9 June 2026, Anthropic shipped Claude Fable 5 for general use and Claude Mythos 5 for a tight circle of cyber defenders and infrastructure partners (Project Glasswing), with biology access planned under trusted programs later.

They are the same underlying Mythos-class model. The fork is product policy, not a second training run: Fable keeps external classifiers and fallbacks that route some cyber/bio-shaped queries to Opus 4.8; Mythos lifts those safeguards in scoped domains. Anthropic’s naming note is explicit — fabula vs mythos — the story you tell vs the unprotected substrate.

List price: $10 / MTok input, $50 / MTok output for both — under half of Mythos Preview. Capability claims are long-horizon first: Stripe-style multi-month migrations compressed into days, Hebbia finance SOTA, vision-only Pokémon FireRed, file-memory gains on long games, and Mythos-side drug-design / genomics loops with heavy tool use.

Access was not smooth. Public Fable/Mythos access was suspended around 12 June under US export/control pressure, then restored 1 July. That pause is part of the story, not a footnote: the frontier model and the policy layer now ship on the same release train.

Why this is interesting

  • Safety as product SKU — One weights stack, two commercial surfaces. “Safe enough for GA” is no longer only RLHF inside the net; it is a classifier gate with known false positives (Anthropic: under 5% of sessions on average, still non-zero pain for real work).
  • Mythos is the honest cyber story — Glasswing and trusted access admit what GA cannot: peak cyber capability is a governed resource, not a chat default. That collides with defender workflows that need ugly tokens (see ExploitGym / HF).
  • Long-horizon is the pitch — Benchmarks matter; the customer quotes that matter more are multi-day engineering and knowledge jobs. Fable is sold as the model that stays useful when the task stops fitting in one prompt.
  • Price signals scarcity theater — $10/$50 is expensive relative to open 3T-class APIs that followed weeks later, cheap relative to prior Mythos Preview. Capacity staging on subscriptions (included window, then credits) shows demand management is part of the release.
  • Judgment stays outside the model — Choosing Fable vs Mythos, when to accept fallback, when to move work to open weights or VPC — that is operator policy. The model does not choose its own containment level in production; the buyer does.

Bottom line

Fable/Mythos is the clearest Western statement yet that frontier capability and deployment permission are separable products. Same intelligence substrate; different stop conditions. Everything that followed in July — Sol GA, open K3/Qwen pressure, eval breakouts — lands on that fork.